News Photos
Results 1 - 20 of 33 in Aceon, Perindopril (generic)
-
Atrial fibrillation increases risk of death in diabetics
Atrial fibrillation is a strong independent predictor of overall mortality and cardiovascular events in diabetic patients, according to findings published in the May issue of the European Heart Journal. Comment?
-
[Scientific Contribution] Comparison of the Effects of...
From the Clinical Pharmacology Unit , University of Cambridge, Addenbrooke's Hospital, Cambridge; and Wales Heart Research Institute , Cardiff University, Cardiff, United Kingdom. Comment?
-
CHINGFORD: Pharmacist supplied out-of-date drugs
A SEVERELY ill grandfather-of-five was given out-of-date and potentially harmful drugs by a pharmacist. Comment?
-
Sinobiopharma announces Chinese approval of Perindopril
Sinobiopharma, Inc. has announced that it has received approval from the Chinese State Food and Drug Administration to manufacture and market its formulation of Perindopril, an anti-hypertension drug. Comment?
-
Sussex nurse accused of dishing out the wrong drugs
A bungling nurse accused of repeatedly giving patients the wrong drugs was put under special supervision just six months into her job, a misconduct hearing was told. Comment?
-
Long term monitoring in patients receiving treatment to lower blood...
OBJECTIVE: To determine the value of monitoring blood pressure by quantifying the probability that observed changes in blood pressure reflect true changes. Comment?
-
the World in Medicine: Arrhythmia and Diabetes
Arrhythmia and Diabetes JAMA. 2009;301 :1529. Individuals with type 2 diabetes who also have atrial fibrillation have a substantially increased risk of cardiovascular events and death, according to an international team of researchers . Comment?
-
Sinobiopharma Seeks Patent for New ACE Inhibitor Formulation
Sinobiopharma has filed for a China patent covering capsule forms of new drug compounds containing Perindopril, an angiotensin-converting enzyme inhibitor. Comment?
-
China Biotech in Review: China Releases Official Health Reform Plans
The big news coming out of China life science last week was the official unveiling of the country's health reform plans, both the long-term plan ending in 2020 and the more immediate three-year program that culminates in 2011. Comment?
-
Sinobiopharma Applies for Chinese Patent to Develop the Next...
NANJING , China , April 6 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. is pleased to announce that it has applied for a single Chinese patent for new drug compounds containing Perindopril, an angiotensin-converting enzyme inhibitor used to treat high blood pressure and heart attack in people with coronary artery disease. Comment?
-
Atrial Fibrillation Linked To An Increased Risk Of Death In Diabetic Patients
The ADVANCE* study of 11,140 patients with type 2 diabetes found that patients who had atrial fibrillation at the start of the trial had a 61% increased risk of dying from any cause, a 77% increased risk of dying from cardiovascular causes such as a heart attack or stroke, and a 68% increased risk of developing heart failure or other ... Comment?
-
Abnormal Heart Rhythm Boosts Death Risk for Diabetics
In people with diabetes, there's a strong association between abnormal heart rhythm, or atrial fibrillation, and increased risk of other heart-related problems and death, according to a study that included ... Comment?
-
Abnormal Heart Rhythm Boosts Death Risk for Diabetics
w/Photo
In people with diabetes, there's a strong association between abnormal heart rhythm, or atrial fibrillation, and increased risk of other heart-related problems and death, according to a study that included ... Comment?
-
Results from a large, international, randomised, controlled trial have shown that there is a strong link between diabetics who have an abnormal heart rhythm and an increased risk of other heart-related problems ... Comment?
-
February 2009 Briefing - Nephrology
In dialysis patients, treatment with blood pressure-lowering medications may significantly reduce rates of cardiovascular morbidity and mortality, according to the results of a study published online Feb. Comment?
-
February 2009 Briefing - Nephrology
In dialysis patients, treatment with blood pressure-lowering medications may significantly reduce rates of cardiovascular morbidity and mortality, according to the results of a study published online Feb. Comment?
-
February 2009 Briefing - Diabetes & Endocrinology
In the United Kingdom, the prevalence of type 2 diabetes increased from 2.8 percent in 1996 to 4.3 percent in 2005, according to a report published online Feb. Comment?
-
Drug Combination Reduces Kidney Disease Risk In Diabetics
The analysis was based on the randomized ADVANCE study, which included 11,140 patients with type two diabetes. Comment?
-
Drug Combo Cuts Kidney Problems in Diabetics
Treatment with the blood pressure drugs perindopril and indapamide can help prevent kidney problems in patients with type 2 diabetes, according to a report in the Journal of the American Society of Nephrology. Comment?
-
Two-Drug Combo May Lower Diabetics' Kidney Risk
A combination of two blood pressure-lowering drugs reduced the risk of kidney disease by about 20% in people with type 2 diabetes , according to researchers who analyzed data from a study that included more ... Comment?
Aceon, Perindopril Forum
Most Popular
